Skip to content
Screener

Aura Biosciences, Inc. AURA Other Income (Expense)

Other Income (Expense) at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
-$331M-209%
Merck & Co. logo
Merck & Co.MRK
-$99M-1,514%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
-$563M-760%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
$10.01M-18.1%
CG Oncology logo
CG OncologyCGON
$7.35M+0.4%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$5M-37.5%

Other financials

Income statement

See full
Operating income-$34.9M-20.1%
Net income-$33.7M-22.6%
EPS (diluted)-$0.50+9.1%

Balance sheet

See full
Cash & equivalents$84.8M+122%
Total debt$17.0M-7.9%
Total equity$107.2M-16.2%
Total assets$137.7M-11.4%

Cash flow

See full
Operating cash flow-$29.9M-28.0%
CapEx$102.0K-45.5%
Free cash flow-$30.0M-27.4%

Valuation

See full
Market cap$826.46M+87.8%
Enterprise value$758.65M+118%

Returns & leverage

See full
Return on equity-95.6%+222pp
Debt / equity0.2×0.0×
Current ratio7.1×-4.0×

Where this comes from

Reported directly by Aura Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.

The source filing: Aura Biosciences, Inc.’s 10-Q, filed May 11, 2026.

Filed
May 11, 2026, 4:15 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-216808
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Other income (expense):
Interest income, including amortization and accretion income1,1901,594
Other income (expense)2(24)
Total other income1,1921,570
Loss before income taxes(33,674)(27,465)
Income tax provision, net(11)(18)
Net loss$(33,685)$(27,483)
Net loss per common share—basic and diluted$(0.50)$(0.55)

Item 1. Financial Statements.

FAQ

What is Aura Biosciences, Inc.'s other income (expense)?
Aura Biosciences, Inc. (AURA) reported other income (expense) of $1.19M in Q1 2026.
How has Aura Biosciences, Inc.'s other income (expense) changed year-over-year?
Aura Biosciences, Inc.'s other income (expense) decreased by 24.1% year-over-year, from $1.57M to $1.19M.
What is the long-term trend for Aura Biosciences, Inc.'s other income (expense)?
Over 4 years (2021 to 2025), Aura Biosciences, Inc.'s other income (expense) has grown at a 805.0% compound annual growth rate (CAGR), from -$1K to $6.71M.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.

Ask your AI about Aura Biosciences, Inc.'s other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude